Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Recent evidence suggests that neural stem/precursor cells (NPCs) promote recovery in animal models with delayed neuronal death via a number of indirect bystander effects. A comprehensive knowledge of how transplanted NPCs exert their therapeutic effects is still lacking. Here, we investigated the effects of a delayed transplantation of adult syngenic NPCs--injected intravenously 72 h after transient middle cerebral artery occlusion--on neurological recovery, histopathology and gene expression. NPC-transplanted mice showed a significantly improved recovery from 18 days post-transplantation (dpt) onwards, which persisted throughout the study. A small percentage of injected NPCs accumulated in the brain, integrating mainly in the infarct boundary zone, where most of the NPCs remained undifferentiated up to 30 dpt. Histopathological analysis revealed a hitherto unreported very delayed neuroprotective effect of NPCs, becoming evident at 10 and 30 dpt. Tissue survival was associated with downregulation of markers of inflammation, glial scar formation and neuronal apoptotic death at both mRNA and protein levels. Our data highlight the relevance of very delayed degenerative processes in the stroke brain that are intimately associated with inflammatory and glial responses. These processes may efficaciously be antagonized by (stem) cell-based strategies at time-points far beyond established therapeutic windows for pharmacological neuroprotection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In rodents, beneficial effects were reported even when treatments were initiated days, weeks, or months after stroke.14–20”
From Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation (2012) · cites this paper as [14]
In the citing paper
“In addition to the sprouting of pyramidal tract fibres, remodelling of transcallosal projections connecting the two motor cortices occurs.14,25”
From Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation (2012) · cites this paper as [14]
In the citing paper
“By contrast with neuroprotection, which requires an acute intervention, treatments promoting neurological recovery by remodelling of brain tissue can be instituted during the stroke recovery phase.10–15”
From Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation (2012) · cites this paper as [14]
In the citing paper
“Microvessels and neuroblasts mutually support each other via release of trophic factors, resulting in a tight interplay that stimulates brain remodelling processes, reducing delayed neuronal degeneration,14,45 promoting neuronal plasticity,15 modulating glial responses,14,46 and attenuating brain inflammation14,46 (figure 2).”
From Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation (2012) · cites this paper as [14]
In the citing paper
“The finding that neural precursor cells prevent ischaemic injury and promote neurological recovery could be attributed to bystander effects related to the interaction of neuroblasts with the microvasculature in the vicinity of the ischaemic lesion, which creates an environment that promotes brain remodelling (figure 2).14,15,37,45”
From Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation (2012) · cites this paper as [14]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Dávalos, A., Guidetti, D., Larrue, V., Lees, K. R., Medeghri, Z., Machnig, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804656 · Cited by 6,684 · cited 2×
“This might imply that therapies favouring endogenous tissue repair and/or remodelling may have realistic chances of success also when applied beyond established time-windows of tissue protection, which in the case of thrombolytics in humans are in the range of 3–6 h (Hacke et al., 2008).”
BackgroundPathobiology of ischaemic stroke: an integrated view
Dirnagl, U., Iadecola, C., & Moskowitz, M. A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01401-0 · Cited by 3,943 · cited 1×
“In the ischaemic border zone surrounding the evolving infarct, inflammatory responses and apoptotic programs are activated in this phase that further contribute to injury development (Dirnagl et al., 1999; Hermann et al., 2001; Hossmann, 2006).”
BackgroundWest, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994 · cited 2×
“Forty-five minutes of MCAO were induced in adult male 8- to 10-week old (weight 20–25 g) C57Bl/6 mice (Harlan Nossan, Netherlands), as previously described (Hata et al., 2000; Hermann et al., 2001).”
MethodInfluentialSelf-citationThe glial scar and central nervous system repair
Fawcett, J. W., & Asher, R. A. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00072-6 · Cited by 1,803 · cited 2×
“Following the acute stroke phase, the tissue undergoes substantial matrix remodelling that results in (astro)glial scar formation, which is widely regarded as a major hampering factor for tissue repair and regeneration (Fawcett and Asher, 1999; Nedergaard and Dirnagl, 2005; Yiu and He, 2006).”
BackgroundInfluentialGlial inhibition of CNS axon regeneration
Yiu, G., & He, Z. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1956 · Cited by 1,495 · cited 2×
“Gliotic scar formation is regarded as a major factor hampering recovery from stroke (Li et al., 2005; Yiu and He, 2006).”
BackgroundInfluentialRegulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke
Liesz, A., Suri-Payer, E., Veltkamp, C., Doerr, H., Sommer, C., Rivest, S., Giese, T., & Veltkamp, R. (2009) · Nature Medicine · doi:10.1038/nm.1927 · Cited by 1,115 · cited 1×
“Further, the importance of both TNF- and IFN-g is emphasized by the demonstration that antagonization of the production of either of these inflammatory cytokines significantly prevented secondary infarct growth after stroke (Liesz et al., 2009).”
BackgroundInjection of adult neurospheres induces recovery in a chronic model of multiple sclerosis
Pluchino, S., Quattrini, A., Brambilla, E., Gritti, A., Salani, G., Dina, G., Galli, R., Del Carro, U., Amadio, S., Bergami, A., et al. (2003) · Nature · doi:10.1038/nature01552 · Cited by 1,068 · cited 3×
“Key functions such as the replacement of neural cells (Pluchino et al., 2003; Karimi-Abdolrezaee et al., 2006) and the delivery of therapeutic gene(s) (Lee et al., 2007) have been recently challenged by intrinsic bystander capacities, mainly exerted by undifferentiated NPCs, releasing at the site…”
BackgroundMethodInfluentialSelf-citationInterleukin-1 and neuronal injury
Allan, S. M., Tyrrell, P. J., & Rothwell, N. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1664 · Cited by 992 · cited 2×
“(Barone et al., 1997; Hallenbeck, 2002; Allan et al., 2005) that contribute to the detrimental post-ischaemic brain inflammation in”
BackgroundCentral nervous system injury-induced immune deficiency syndrome
Meisel, C., Schwab, J. M., Prass, K., Meisel, A., & Dirnagl, U. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1765 · Cited by 968 · cited 2×
“…rather than immune-suppressive action exerted by NPCs may be of pivotal interest as stroke is accompanied by an early peripheral immunodeficiency phase (Meisel et al., 2005; Offner et al., 2006; Offner et al., 2009) that limits the application of systemic immunosuppressive therapies.”
BackgroundActivation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia
Namura, S., Zhu, J., Fink, K., Endres, M., Srinivasan, A., Tomaselli, K. J., Yuan, J., & Moskowitz, M. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-10-03659.1998 · Cited by 893 · cited 3×
“That the therapeutic window is so narrow has been explained by the fact that brain infarct evolves very rapidly, typically within a few hours up to 3–4 days after stroke, depending on the duration and severity of ischaemia (Garcia et al., 1993; Namura et al., 1998; Hata et al., 2000; Li et al., 2000; Hermann et al., 2…”
BackgroundInfluential
Cited by
Items 201–300 of 350
Lee, H. I., Lee, S., Kim, N. G., Park, K., Choi, B. T., Shin, Y., & Shin, H. K. (2017) · Journal of Biophotonics · doi:10.1002/jbio.201700038 · Cited by 28
Huang, H., Qian, K. X., Han, X., Li, X., Zheng, Y., Chen, Z., Huang, X., & Chen, H. (2018) · Stem Cells International · doi:10.1155/2018/4826407 · Cited by 32
Zanier, E. R., Pischiutta, F., Villa, P., Paladini, A., Montinaro, M., Micotti, E., Orrù, A., Cervo, L., & Simoni, M. G. D. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12128 · Cited by 26
Sandu, R. E., Balseanu, A. T., Cătălin, B., SLEVIN, M. A., Petcu, E. B., & Popa‐Wagner, A. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.01.008 · Cited by 23
“Over the past 20 years, suitable models for stroke in aged rats have been established Bacigaluppi et al., 2009.”
BackgroundNeural stem cell secretome and its role in the treatment of neurodegenerative disorders
Zhang, Q. Y., Li, J., An, W.-Q., Fan, Y., & Cao, Q. (2020) · Journal of Integrative Neuroscience · doi:10.31083/j.jin.2020.01.1142 · Cited by 33
Giebel, B., & Hermann, D. M. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.03.49 · Cited by 23
Self-citationKılıç, E., Reitmeir, R., Kılıç, Ü., Çağlayan, A. B., Beker, M. Ç., Keleştemur, T., Ethemoğlu, S., Öztürk, G., & Hermann, D. M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00422 · Cited by 26
“, 2011, 2012)], and neural precursor/stem cells (Bacigaluppi et al., 2009; Andres et al., 2011) have been administered.”
BackgroundSelf-citationFunctions of subventricular zone neural precursor cells in stroke recovery
Williamson, M. R., Jones, T. A., & Drew, M. R. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112209 · Cited by 24
“For example, Bacigallupi and colleagues [109] administered neural stem cells (from cultures of isolated adult mouse SVZ NPCs) intravenously 72 hours after transient MCAo in young adult mice.”
BackgroundMethodHuman Fetal Neural Stem Cells for Neurodegenerative Disease Treatment
Ferrari, D., Gelati, M., Profico, D. C., & Vescovi, A. L. (2018) · Results and problems in cell differentiation · doi:10.1007/978-3-319-93485-3_14 · Cited by 23
Phosphodiesterase 10A Is a Critical Target for Neuroprotection in a Mouse Model of Ischemic Stroke
Beker, M. Ç., Çağlayan, A. B., Altunay, S., Özbay, E., Ateş, N., Keleştemur, T., Çağlayan, B., Kılıç, Ü., Doeppner, T. R., Hermann, D. M., et al. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02621-5 · Cited by 22
Self-citationWu, S., Fitzgerald, K. T., & Giordano, J. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00602 · Cited by 24
“, the “bystander” “mechanism” in SCI, see (262) for overview; (132, 155) for ischemic stroke], neurotrophic support (262); immunomodulation (164), and cell replacement and integration (111).”
BackgroundDrug-like delivery methods of stem cells as biologics for stroke
Tuazon, J. P., Castelli, V., & Borlongan, C. V. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1645116 · Cited by 22
“these exogenous cells remain undifferentiated [116].”
Neural Stem Cell-Based Therapy for Ischemic Stroke
Kokaia, Z., & Darsalia, V. (2011) · Translational Stroke Research · doi:10.1007/s12975-011-0100-6 · Cited by 21
“Transplanted NSCs had an anti-inflammatory effect [42, 44 , 45] and genemodified stem cells expressing neurotrophins and antiapoptotic enzymes have provided neuroprotection and improved impaired neurological function [46–49].”
BackgroundÇağlayan, A. B., Beker, M. Ç., Sertel, E., Çağlayan, B., Kılıç, Ü., Ateş, N., Çağlayan, A., Dasdelen, M. F., Doeppner, T. R., Saarma, M., et al. (2022) · Translational Stroke Research · doi:10.1007/s12975-022-01035-2 · Cited by 21
Self-citationPoststroke Cell Therapy of the Aged Brain
Popa‐Wagner, A., Aldea, M., Uzoni, A., Pourgolafshan, P., & Buga, A.-M. (2015) · Neural Plasticity · doi:10.1155/2015/839638 · Cited by 25
“Nuclei are labelled with DAPI (blue) (modified after [36]).”
BackgroundHigh-Mobility Group Box 1: An Amplifier of Stem and Progenitor Cell Activity After Stroke
Hayakawa, K., Pham, L. D., Arai, K., & Lo, E. H. (2013) · Acta neurochirurgica. Supplementum · doi:10.1007/978-3-7091-1434-6_5 · Cited by 23
“Importantly, mouse NSCs delivered intravenously 3 days after stroke in mice have been shown to suppress inflammation and glial scar formation and give rise to delayed neuroprotection and improved functional recovery, starting 18 days after the insult [4].”
BackgroundPayne, N. L., Sun, G., Herszfeld, D., Goh, P. A., Verma, P. J., Parkington, H. C., Coleman, H. A., Tonta, M. A., Siatskas, C., & Bernard, C. C. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035093 · Cited by 21
Luciani, M., Gritti, A., & Meneghini, V. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00224 · Cited by 20
Lim, Y. S., & Tang, B. L. (2012) · Cell Communication & Adhesion · doi:10.3109/15419061.2012.712574 · Cited by 20
“…be conferred by the secretion of soluble factors by the transplanted cells, which would enhance either the survival or regeneration of spared neurons, or the proliferation and eventual differentiation of endogenous progenitor cells, or act by suppressing infl ammation (Bacigaluppi et al., 2009).”
BackgroundZhang, Y., Zhang, M., Zhang, R., Liu, H., Chen, H., Zhang, X., Li, C., Zeng, Q., Chen, Y., & Huang, G. (2022) · Frontiers in Materials · doi:10.3389/fmats.2022.914994 · Cited by 31
“NSCs delivery in the early stroke phase attenuates this complex inflammatory signaling cascade (Bacigaluppi et al., 2009; De Feo et al., 2012).”
BackgroundKlein, R. M., Mahlberg, N., Ohren, M., Ladwig, A., Neumaier, B., Graf, R., Hoehn, M., Albrechtsen, M., Rees, S., Fink, G. R., et al. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9694-5 · Cited by 22
“Numerous studies have tried to influence ischemic lesions and neural loss by transplanting neural stem cells (Bacigaluppi et al., 2009, Chopp et al., 2009, Doeppner et al., 2012) with the risk of cell death after transplantation, failed integration into neural networks, and the formation of tumors…”
BackgroundXia, W., & Geng, K. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.07.020 · Cited by 19
Noh, J.-E., Oh, S.-H., Lee, S., Lee, S., Kim, Y. H., Park, H., Ju, J., Kim, H., Huh, J., & Song, J. (2020) · Cell Proliferation · doi:10.1111/cpr.12884 · Cited by 21
Neural Stem Cells and Its Derivatives as a New Material for Melanin Inhibition
Hwang, I.-S., & Hong, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms19010036 · Cited by 21
Probing Interleukin-6 in Stroke Pathology and Neural Stem Cell Transplantation
Lockard, G., Alayli, A., Monsour, M., Gordon, J., Schimmel, S. J., Elsayed, B., & Borlongan, C. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415453 · Cited by 18
“Overall, the attenuation of the immune response decreased glial scarring and secondary injury following stroke [35].”
BackgroundFainstein, N., Dan-Goor, N., & Ben‐Hur, T. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.07.020 · Cited by 17
Yang, J., Kim, E., Beltran, C., & Cho, S. (2019) · Stroke · doi:10.1161/strokeaha.119.026053 · Cited by 18
Regenerative Medicine for Stroke – Are We There Yet?
Onteniente, B., & Polentes, J. (2011) · Cerebrovascular Diseases · doi:10.1159/000324325 · Cited by 19
“The emphasis can be put on generating discrete neuronal populations.A second aspect of graft integration is the participation in brain rewiring. Here again, available data are sparse, probably due to technical difficulties. Reports show that grafted NSC promote axonal sprouting [”
Kang, I. N., Lee, C. Y., & Tan, S. C. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e02156 · Cited by 20
Li, L., Saiyin, H., Xie, J., Ma, L., Xue, L., Wang, W., Liang, W., & Yu, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.15325 · Cited by 17
Mechanisms and use of neural transplants for brain repair
Dunnett, S. B., & Björklund, A. (2017) · Progress in brain research · doi:10.1016/bs.pbr.2016.11.002 · Cited by 17
“The immature grafted precursor cells are considered to exert a neuroprotective influence on slowly evolving neurodegenerative processes by dissipating host inflammatory reactions, reducing glial scar formation, and inhibiting apoptotic cell death pathways (Bacigaluppi et al., 2009).”
Rewiring the ischaemic brain with human-induced pluripotent stem cell-derived cortical neurons
Pluchino, S., & Peruzzotti‐Jametti, L. (2013) · Brain · doi:10.1093/brain/awt330 · Cited by 19
“…of the host immune system, the inhibition of astroglial responses and/or the modulation of endogenous neuronal function) is needed to improve fine-tuning of the stem cell bystander activities and their neurogenic potential, eventually leading to maximum recovery (Bacigaluppi et al., 2009).”
Fainstein, N., Cohen, M. E., & Ben‐Hur, T. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.08.004 · Cited by 17
Promoting Neurological Recovery in the Post-Acute Stroke Phase: Benefits and Challenges
Hermann, D. M., & Chopp, M. (2014) · European Neurology · doi:10.1159/000365171 · Cited by 15
Self-citationMinassian, A., Green, C., Diedenhofen, M., Vogel, S. N., Heß, S., Stoeber, M., Radmilović, M. D., Wiedermann, D., Kloppenburg, P., & Hoehn, M. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00086 · Cited by 15
de Carvalho, T. S., Sánchez-Mendoza, E. H., Moreira, A. R. S., Melo, L. M. N., Wang, C., Sardari, M., Hagemann, N., Doeppner, T. R., Kleinschnitz, C., & Hermann, D. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02207-7 · Cited by 18
Self-citationOxygen–Glucose Deprived Peripheral Blood Mononuclear Cells Protect Against Ischemic Stroke
Otsu, Y., Hatakeyama, M., Kanayama, T., Akiyama, N., Ninomiya, I., Omae, K., Kato, T., Onodera, O., Fukushima, M., Shimohata, T., et al. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01398-w · Cited by 18
Neurogenesis or non-neurogenesis: that is the question
Martino, G., Butti, E., & Bacigaluppi, M. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74419 · Cited by 15
“Various approaches have consistently shown that transplanted SVZ-derived NPCs, while remaining undifferentiated, promote CNS tissue healing via secretion of immunomodulatory and neuroprotective molecules capable of reducing detrimental responses (the so-called bystander effect) (11–14).”
Self-citationLiu, Q., Zhang, L., & Zhang, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110981 · Cited by 17
Radiopharmaceutical Stem Cell Tracking for Neurological Diseases
Rosado-de-Castro, P. H., Pimentel‐Coelho, P. M., Gutfilen, B., de Souza, S. A. L., de Freitas, G. R., Méndez‐Otero, R., & da Fonseca, L. M. B. (2014) · BioMed Research International · doi:10.1155/2014/417091 · Cited by 18
“Actually, even the therapeutic efficacy of cells committed to the neural fate, such as neural stem/progenitor cells, seems to be at least partially related to the secretion of innumerous neurotrophic, anti-inflammatory, and proangiogenic factors that contribute to CNS repair [61, 62].”
BackgroundReview: Could neurotransmitters influence neurogenesis and neurorepair after stroke?
Sánchez-Mendoza, E. H., Bellver‐Landete, V., Merino, J. J., González, M. P., Martínez‐Murillo, R., & Oset‐Gasque, M. J. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12082 · Cited by 15
Biomaterial applications in neural therapy and repair
Ghuman, H., & Modo, M. (2016) · Chinese Neurosurgical Journal · doi:10.1186/s41016-016-0057-0 · Cited by 20
Gao, J., Bai, H.-J., Li, Q., Li, J., Wan, F., Tian, M., Li, Y., Song, Y., Zhang, J., & Yin-chu, S. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3253 · Cited by 13
“The NSCs have neuroprotective functions due to their anti-inflammatory, glial scar-inhibitory, and anti-apoptotic effects; accordingly, they promote the recovery of patients with neurological disease (9).”
Out of the core: the impact of focal ischemia in regions beyond the penumbra
Koukalova, L., Chmelová, M., Amlerova, Z., & Vargová, L. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1336886 · Cited by 17
“…al., 2001; Kronenberg et al., 2012; Prinz et al., 2015) longer occlusions (45–120 min) begin to involve the parietal cortex (Arvidsson et al., 2001; Bacigaluppi et al., 2009; Garbuzova-Davis et al., 2014; Cai et al., 2017; Gaire et al., 2019), and a 3-h occlusion spreads even further to the globus…”
BackgroundInfluentialStem Cell Therapy for Ischaemic Stroke: Translation from Preclinical Studies to Clinical Treatment
Balami, J. S., Fricker, R. A., & Chen, R. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312020007 · Cited by 14
Hosseini, S., Samimi, N., Farahmandnia, M., Sarvestani, F. S., Sani, M., Mohamadpour, M., & Shakibajahromi, B. (2015) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.166216 · Cited by 16
“[15] Furthermore, NSCs have been transplanted for treating ischemic stroke and the results show they have improved neurological function and reduced brain lesion via the capability of immunomodulatory, trophic, and regeneration.[16-18] According to mentioned above, we tested the preventive effects of NSCs and MSCs tha…”
MethodDong, C., Hu, S., Liu, J., & Li, S. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7176 · Cited by 14
Neural Stem Cell Transplantation and Mechanisms for Functional Recovery
Oliveira, A. A. D., Sánchez, J. P. B., & Hurtado, J. C. (2016) · Journal of Stem Cell Research & Therapeutics · doi:10.15406/jsrt.2016.01.00012 · Cited by 13
“Models of ischemia have also shown down regulation of markers of inflammation, glial scar formation and neuronal apoptotic death by NSCs influence at gene level [135].”
BackgroundFührmann, T., Gerardo‐Nava, J., & Brook, G. A. (2010) · Springer eBooks · doi:10.1007/978-3-642-02824-3_12 · Cited by 14
Intravascular Stem Cell Transplantation for Stroke
Auriat, A. M., Rosenblum, S., Smith, T. N., & Guzman, R. G. (2011) · Translational Stroke Research · doi:10.1007/s12975-011-0093-1 · Cited by 14
“Neuroprotection occurs when stem cell treatment is administered 3 days after injury in experimental stroke models [35]; however, reductions in atrophy are seen even when stem cell treatments are delayed until 3 weeks after stroke [36].”
Sánchez-Mendoza, E. H., & Hermann, D. M. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00196 · Cited by 13
“or pharmacological compounds, which in rodent and primate models of stroke were shown to enhance neurological recovery (Bacigaluppi et al., 2009; Reitmeir et al., 2011, 2012; Jaeger et al., 2015; Wang et al., 2016).”
BackgroundSelf-citationDual effect of C–C motif chemokine receptor 5 on ischemic stroke: More harm than benefit?
Jing, K., Chen, F., Shi, X., Guo, J., & Liu, X. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175857 · Cited by 16
Enabling Survival of Transplanted Neural Precursor Cells in the Ischemic Brain
Wang, Z., Zheng, D., Tan, Y. S., Yuan, Q., Fang, Y., & Zhang, S. (2023) · Advanced Science · doi:10.1002/advs.202302527 · Cited by 12
Kılıç, Ü., Elibol, B., Çağlayan, A. B., Beker, M. Ç., Beker, M., Altuğ, B., Uysal, Ö., Yılmaz, B., & Kılıç, E. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-01995-y · Cited by 12
Neural differentiation and support of neuroregeneration of non-neural adult stem cells
Abraham, R. G., & Verfaillie, C. M. (2012) · Progress in brain research · doi:10.1016/b978-0-444-59544-7.00002-0 · Cited by 13
Monitoring maturation of neural stem cell grafts within a host microenvironment
Kopach, O. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i11.982 · Cited by 13
Dying transplanted neural stem cells mediate survival bystander effects in the injured brain
Han, W., Meißner, E.-M., Neunteibl, S., Günther, M., Kahnt, J., Dolga, A. M., Xie, C., Plesnila, N., Zhu, C., Blomgren, K., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05698-z · Cited by 16
“In fact, enhanced neuroprotection has been observed even in the absence of neuronal differentiation [13, 14].”
BackgroundYin, D., Wang, C., Qi, Y., Wang, Y., Hagemann, N., Yusuf, A. M., Dzyubenko, E., Kaltwasser, B., Tertel, T., Giebel, B., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02894-8 · Cited by 13
Self-citationC-X-C chemokine receptor type 7 antibody enhances neural plasticity after ischemic stroke
Zhang, X.-Q., Zhang, X., Dong, B.-C., Li, M., Wang, Y., Xiao, T., & Zhao, S.-S. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.363835 · Cited by 12
“Many restorative strategies, such as rehabilitation, antioxidants, and stem cell therapy, have been shown to further improve endogenous neural plasticity after ischemic injury in the brain (Bacigaluppi et al., 2009; Rodrigo et al., 2013; Shiromoto et al., 2017).”
Zhang, Z., Jin, D., Yang, Z., Shen, B., & Liu, M. (2011) · Brain Injury · doi:10.3109/02699052.2010.542430 · Cited by 10
“intraparenchymally injected into stroke animal models have shown that NSCs survive, selectively migrate to ischemic sites, differentiate into astrocytes and neurons and ameliorate neurological deficits [5– 8] at 24 hours post-ischemia [7–9] and 72 hours post-ischemia [10].”
BackgroundRetractedSudharsan, R., Dolgova, N., Kwok, J., Gray, A. P., Sato, Y., Luz-Madrigal, A., Susaimanickam, P. J., Kryukov, E., Baranov, P. Y., Wolfe, J. H. N., et al. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04509-w · Cited by 9
“Similar observations have been reported in studies of neuronal progenitor cell transplantation into the central nervous system, where significant cell death occurs within the first seven days post-trans-plantation [32–35].”
Obara, K., Shirai, K., Hamada, Y., Arakawa, N., Hasegawa, A., Takaoka, N., Aki, R., Hoffman, R. M., & Amoh, Y. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280304 · Cited by 11
Sensors of Succinate: Neural Stem Cell Grafts Fight Neuroinflammation
Kokaia, Z., & Lindvall, O. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.01.019 · Cited by 9
“For example, grafted NSCs have been reported to suppress inflammation after ischemic stroke (Bacigaluppi et al., 2009; Horie et al., 2011; Kelly et al., 2004).”
BackgroundManrique‐Castano, D., Sardari, M., de Carvalho, T. S., Doeppner, T. R., Popa‐Wagner, A., Kleinschnitz, C., Chan, A., & Hermann, D. M. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00412 · Cited by 9
Self-citationBeker, M. Ç., Pence, M. E., Yagmur, S., Çağlayan, B., Çağlayan, A., Kılıç, Ü., Yelkenci, H. E., Altıntaş, M. Ö., Çağlayan, A. B., Doeppner, T. R., et al. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114221 · Cited by 8
Self-citationBernstock, J. D., Verheyen, J., Huang, B. Y., Hallenbeck, J. M., & Pluchino, S. (2014) · InTech eBooks · doi:10.5772/58599 · Cited by 11
Systemic Neural Stem Cell-Based Therapeutic Interventions for Inflammatory CNS Disorders
Doneg, M., Giusto, E., Cossetti, C., & Pluchino, S. (2013) · InTech eBooks · doi:10.5772/55426 · Cited by 12
Ballios, B. G., Baumann, M. D., Cooke, M. J., & Shoichet, M. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-381422-7.10055-0 · Cited by 10
Peruzzotti‐Jametti, L., Bernstock, J. D., Manferrari, G., Rogall, R., Fernández‐Vizarra, E., Williamson, J. C., Braga, A., van den Bosch, A. M. R., Leonardi, T., Kittel, Á., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.29.923441 · Cited by 8
Venketasubramanian, N., Yeo, T. T., & Chen, C. (2024) · Biomolecules · doi:10.3390/biom14060680 · Cited by 9
Wang, P., Liu, P., Ding, Y., Zhang, G., Wang, N., Sun, X., Li, M., Li, M., Bao, X., & Chen, X. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00363 · Cited by 7
Adipose-derived stem cells extract has a proliferative effect on myogenic progenitors
Im, W., Ban, J., Lim, J., Lee, M., Chung, J. Y., Bhattacharya, R., & Kim, S. H. (2014) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-014-9752-3 · Cited by 7
“This phenomenon is also called the “bystander mechanism” (Bacigaluppi et al. 2009).”
BackgroundHuman neural progenitor cells in central nervous system lesions
Åkesson, E., & Sundström, E. (2015) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2015.11.020 · Cited by 7
Neural Stem Cells in Stroke: Intracerebral Approaches
Manley, N. C., Azevedo-Pereira, R. L., Bliss, T. M., & Steinberg, G. K. (2015) · Springer eBooks · doi:10.1007/978-3-319-15063-5_7 · Cited by 8
CD200 -dependent and -independent immune-modulatory functions of neural stem cells
Arad, T., Fainstein, N., Goldfarb, S., Lachish, M., Ganz, T., & Ben‐Hur, T. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102559 · Cited by 7
Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis
Lovato, L., de Rosbo, N. K., & Uccelli, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7953-6_20 · Cited by 7
Green, C., Minassian, A., Vogel, S. N., Diedenhofen, M., Wiedermann, D., & Hoehn, M. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00335 · Cited by 6
Abdel‐Salam, O. M. E., Youness, E. R., Omara, E. A. A., & Sleem, A. A. (2014) · Comparative Clinical Pathology · doi:10.1007/s00580-014-1906-x · Cited by 6
Pascoe, M. C., Howells, D. W., Crewther, S., Crewther, D. P., & Carey, L. M. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s72925 · Cited by 6
Editorial: Stem cells and progenitor cells in ischemic stroke—fashion or future?
Doeppner, T. R., & Hermann, D. M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00334 · Cited by 6
“Although adult NPCs are not integrated into residing neural networks, solid experimental data demonstrates beneficial effects in pre-clinical stroke models (Bacigaluppi et al., 2009; Doeppner et al., 2012).”
BackgroundSelf-citationValente, A., Mariani, J., Seminara, S., Tettamanti, M., Pignataro, G., Perego, C., Sironi, L., Pedata, F., Amantea, D., Bacigaluppi, M., et al. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231159958 · Cited by 5
“Ischemia was performed by transient occlusion of the left or right middle cerebral artery (tMCAo).(14,15) Anaesthesia was administered by inhalation of 3% isoflurane in a gaseous mixture of oxygen and nitrous oxide (N2O/O2, 70%/30%) and maintained with 1.”
MethodSelf-citationSustaining Brain Youth by Neural Stem Cells: Physiological and Therapeutic Perspectives
dos Santos, M. A., Moreira, J. A. F., Santos, S. S., & Solá, S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04774-z · Cited by 8
“Time Is Brain” – for Cell Therapies
Yin, H. R., Brian, D., Weber, R., Lyden, P. D., & Rust, R. (2025) · Advanced Science · doi:10.1002/advs.202519579 · Cited by 7
Guan, Y.-M., Zhu, Y., Liu, X.-C., Huang, H.-L., Wang, Z., Liu, B., Zhu, Y.-Z., & Wang, Q. (2014) · BMC Neuroscience · doi:10.1186/1471-2202-15-41 · Cited by 5
Mesenchymal Stromal Cell Secretome for Tissue Repair
Gnecchi, M., Ciuffreda, M. C., & Mura, M. (2020) · Springer eBooks · doi:10.1007/978-3-319-08831-0_43 · Cited by 6
Tahta, A., İzgi, N., Onder, T. B., Erdağ, E., Aras, Y., & Genc, C. (2017) · Turkish Neurosurgery · doi:10.5137/1019-5149.jtn.21789-17.1 · Cited by 5
“5 mm anteroposterior, +3 mm mediolateral and +5 mm dorsoventrally; (2) -0.”
BackgroundMethodNanomedicine-Mediated Stem Cell Therapeutics in Stroke
Sangwan, N., & Avti, P. (2022) · Springer eBooks · doi:10.1007/978-981-16-8562-0_7 · Cited by 5
Lisjak, D., Alić, I., Šimunić, I., & Mitrečić, D. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1439994 · Cited by 4
Modulation of Post-Stroke Plasticity and Regeneration by Stem Cell Therapy and Exogenic Factors
Andereggen, L., Reitmeir, R., Santo, S. D., Guzman, R. G., Widmer, H. R., Marbacher, S., & Andres, R. H. (2017) · Springer series in translational stroke research · doi:10.1007/978-3-319-66679-2_7 · Cited by 4
Mechanism of action of somatic stem cell treatments: towards the concept of therapeutic plasticity
Martino, G., & Bacigaluppi, M. (2010) · Cytotherapy · doi:10.3109/14653249.2011.537055 · Cited by 4
Self-citationKılıç, Ü., Elibol, B., Beker, M., Altuğ, B., Çağlayan, A. B., Beker, M. Ç., Yılmaz, B., & Kılıç, E. (2021) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2021.106105 · Cited by 4
Sampaio, M. D. F. D. S., Boechat, M. S. B., Cunha, I. A. G., Pereira, M. G., Coimbra, N. C., & Giraldi‐Guimarães, A. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147292 · Cited by 3
Morris, R. H., Chabrier, G., Counsell, S. J., McGonnell, I. M., & Thornton, C. (2022) · Developmental Neuroscience · doi:10.1159/000524829 · Cited by 3
Applications of the stem cell secretome in regenerative medicine
Mendes-Pinheiro, B., Marote, A., Marques, C. R., Teixeira, F. G., Ribeiro, J. C., & Salgado, A. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819713-4.00005-0 · Cited by 7
Robert, S. M., & Matouk, C. (2020) · Springer eBooks · doi:10.1007/978-3-030-56954-9_15 · Cited by 3
Effect of stem cells-based therapy on astrogliosis in stroke subjected-mice
Akhoundzadeh, K., & Vakili, A. (2020) · Stem Cell Investigation · doi:10.21037/sci-2020-031 · Cited by 3
Therapeutic Application of Neural Stem Cells for Neonatal Hypoxic-ischemic Brain Injury
Park, K. I., Goo, K., Jung, K., Kim, M., Kim, I., Yun, S., Lee, I.-S., Shin, J. E., Yu, H. Y., Eun, H. S., et al. (2013) · Neonatal Medicine · doi:10.5385/nm.2013.20.3.343 · Cited by 3
Clinically relevant aspects of stem cell technologies: current state of play
Stuart, M. J., & Pattavilakom, A. (2014) · ANZ Journal of Surgery · doi:10.1111/ans.12864 · Cited by 5
Székiová, E., Michalová, Z., Blaško, J., Mucha, R., Slovinská, L., Kello, M., & Vanický, I. (2023) · Growth Factors · doi:10.1080/08977194.2023.2182145 · Cited by 3
“They have been confirmed by various studies to be effective in preventing neuronal programmed cell death and glial scars caused by SCI, ischaemic stroke, cerebrovascular accident or demyelinating disorders (Cantinieaux et al., 2013; Drago et al., 2013; Bacigaluppi et al., 2009; Ziv et al., 2006).”
BackgroundDCX+ cells cripple systemic spleen immunity and promote tumor progression
Ren, D., He, Y., Lu, C., Fu, Y., Wang, Y., Hu, Q., Ni, Y., Song, Y., Li, Y., & Ding, L. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106076 · Cited by 2
Metadata
- Authors
- Bacigaluppi, M., Pluchino, S., Jametti, L. P., Kilic, E., Kilic, Ü., Salani, G., Brambilla, E., West, M. J., Comi, G., Martino, G., & Hermann, D. M.
- Affiliations
- University Hospital Zurich (CH)
- IRCCS Ospedale San Raffaele (IT)
- Aarhus University (DK)
- Corresponding author
- Hermann, Dirk M.
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-07-16
- Volume
- 132
- Issue
- 8
- Pages
- 2239-2251
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2117381245
- Cited by
- 350
- References
- 59
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 8 · 2023: 15 · 2022: 17 · 2021: 14 · 2020: 26 · 2019: 22 · 2018: 22 · 2017: 24 · 2016: 29 · 2015: 27 · 2014: 33 · 2013: 29 · 2012: 32
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- reroDoc Digital Library (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (112056, 3200B0)
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- neural stem cell transplantation, ischemic stroke, middle cerebral artery occlusion, bystander effect, neuronal apoptosis, glial scar formation, neuroinflammation, delayed neuronal death, neurological recovery, gene expression
- MeSH terms
- Animals, Astrocytes, Atrophy, Brain, Cell Survival, Cicatrix, Corpus Callosum, Disease Models, Animal, Gene Expression Regulation, Inflammation, Male, Mice, Inbred C57BL, Neurons, Disease Progression, Stroke, Gene Expression Profiling, Stem Cell Transplantation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.